Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 8/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.63 |
| ▸ | MAPT | P10636 | 6/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.63 |
| ▸ | HPGD | P15428 | 4/20 | 0.63 |
| ▸ | GFER | P55789 | 4/20 | 0.63 |
| ▸ | THRB | P10828 | 3/20 | 0.63 |
| ▸ | HTT | P42858 | 1/20 | 0.63 |
| ▸ | PLEC | Q15149 | 1/20 | 0.63 |
| ▸ | NEU3 | Q9UQ49 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.58 |
| ▸ | NPC1 | O15118 | 3/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | GLA | P06280 | 1/20 | 0.58 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.55 |
| ▸ | PRKCI | P41743 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8374327 | 0.98 | GAA (0.61) | GAAKDM4EMAPTALDH1A1HPGD | |
| SCHEMBL7105521 | 0.87 | PRKCI (0.71) | GAAKDM4EMAPTALDH1A1HPGD | |
| SCHEMBL10600114 | 0.86 | PRKCI (0.54) | GAAKDM4EMAPTALDH1A1HPGD | |
| SCHEMBL15942895 | 0.86 | HDAC1 (0.61) | GAAKDM4EMAPTALDH1A1HPGD | |
| SCHEMBL11789120 | 0.83 | ALDH1A1 (0.58) | GAAKDM4EMAPTALDH1A1HPGD | |
| SCHEMBL3891611 | 0.83 | NPC1 (0.64) | GAAKDM4EMAPTALDH1A1HPGD | |
| SCHEMBL9136207 | 0.83 | ALDH1A1 (0.62) | GAAKDM4EMAPTALDH1A1HPGD | |
| SCHEMBL8367216 | 0.82 | HDAC1 (0.71) | GAAKDM4EMAPTALDH1A1HPGD | |
| SCHEMBL1067119 | 0.81 | PRKCI (0.73) | GAAKDM4EMAPTALDH1A1HPGD | |
| SCHEMBL8887281 | 0.81 | GAA (0.58) | GAAKDM4EMAPTALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5602277-A | Substituted benzene derivatives useful as neuraminidase inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 1997-02-11 | — | — | US | claimed |
| WO-1996030329-A1 | SUBSTITUTED BENZENE DERIVATIVES USEFUL AS NEURAMINIDASE INHIBITORS | BIOCRYST PHARMACEUTICALS, INCORPORATED (US) | 1996-10-03 | — | — | WO | claimed |
| EP-4343775-A1 | A METHOD FOR DETERMINING A MEDICAL OUTCOME FOR AN INDIVIDUAL, RELATED ELECTRONIC SYSTEM AND COMPUTER PROGRAM | SurgeCare (FR) | 2024-03-27 | — | — | EP | disclosed |
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| EP-3320921-B1 | FORMULATIONS FOR ENHANCED BIOAVAILABILITY OF ORALLY ADMINISTERED POLAR AGENTS | ALA WAI PHARMA INC (US) | 2022-01-05 | — | — | EP | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20200278346-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ADJACENT ACQUISITION CO., LLC | 2020-09-03 | — | — | US | disclosed |
| EP-3681504-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | Icagen, Inc. (US) | 2020-07-22 | — | — | EP | disclosed |
| WO-1996039838-A1 | METHODS OF INHIBITING BACTERIAL SIALIDASE | UNIVERSITY OF ALABAMA (US) | 1996-12-19 | — | — | WO | disclosed |
| EP-0685470-A2 | Benzene derivatives and pharmaceutical composition | Kureha Chemical Industry Co., Ltd. (JP) | 1995-12-06 | — | — | EP | disclosed |
| WO-1995028376-A1 | INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE AND METHODS OF MAKING AND USING THE SAME | THE UNIVERSITY OF ALABAMA AT BIRMINGHAM (US) | 1995-10-26 | — | — | WO | disclosed |
| US-5453533-A | Enzyme inhibitor | THE UNIVERSITY OF ALABAMA AT BIRMINGHAM (US) | 1995-09-26 | — | — | US | disclosed |
| EP-0649883-A1 | Pigment compositions | CIBA-GEIGY AG (CH) | 1995-04-26 | — | — | EP | disclosed |
| US-5256772-A | Colorant for gravure offset or inks, coatings, clarity | TOYO INK MANUFACTURING CO., LTD. (JP) | 1993-10-26 | — | — | US | disclosed |
| EP-0480705-A1 | Monoazo lake pigment, process for producing the same and its use | TOYO INK MANUFACTURING CO., LTD. (JP) | 1992-04-15 | — | — | EP | disclosed |
| US-4810302-A | STORAGE STABLE MIXTURES | TOYO INK MANUFACTURING CO., LTD. (JP) | 1989-03-07 | — | — | US | disclosed |
| US-4039672-A | EMESIS | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE (FR) | 1977-08-02 | — | — | US | disclosed |